Cargando…

Antitumor activity of recombinant RGD-IFN-α2a-core fusion protein in vitro

Interferon (IFN) regulates immune responses and antitumor activity. Arginine–glycine–aspartic acid (RGD) peptides can specifically bind to integrin α(v)β(3), a transmembrane receptor that is highly expressed on the surface of various cancer cells. In this study, we expressed recombinant RGD-IFN-α2a-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Zhengwei, Jia, Qunying, Kang, Xiaojuan, Lou, Yongliang, Zou, Lilin, Yang, Jifeng, Gao, Jimin, Han, Liping, Li, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Preclinical Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131691/ https://www.ncbi.nlm.nih.gov/pubmed/27759573 http://dx.doi.org/10.1097/CAD.0000000000000421

Ejemplares similares

Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy
por: Wardell, Suzanne E., et al.
Publicado: (2019)

Liver X receptor agonist T0901317 inhibits the migration and invasion of non-small-cell lung cancer cells in vivo and in vitro
por: Lou, Rui, et al.
Publicado: (2019)

Antitumor activity of a rhenium (I)-diselenoether complex in experimental models of human breast cancer
por: Collery, Philippe, et al.
Publicado: (2015)

Antitumor and immunomodulatory effects of a novel multitarget inhibitor, CS2164, in mouse hepatocellular carcinoma models
por: Zhou, You, et al.
Publicado: (2019)

Recurrent read-through fusion transcripts in breast cancer
por: Varley, Katherine E., et al.
Publicado: (2014)

Survivin contributes to DNA repair by homologous recombination in breast cancer cells
por: Véquaud, Eloïse, et al.
Publicado: (2015)

RAD1901: a novel, orally bioavailable selective estrogen receptor degrader that demonstrates antitumor activity in breast cancer xenograft models
por: Garner, Fiona, et al.
Publicado: (2015)

Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models
por: Bergman, Andries M., et al.
Publicado: (2010)

Quantitative proteomic analysis reveals that Luks-PV exerts antitumor activity by regulating the key proteins and metabolic pathways in HepG2 cells
por: Zhao, Chang-Cheng, et al.
Publicado: (2020)

Numerical and physical modeling of breast cancer based on image fusion and artificial intelligence
por: Dołęga-Kozierowski, Bartosz, et al.
Publicado: (2023)

Self-assembled HCV core virus-like particles targeted and inhibited tumor cell migration and invasion
por: Li, Xiang, et al.
Publicado: (2013)

Improved in vivo antitumor effect of a daunorubicin - GnRH-III bioconjugate modified by apoptosis inducing agent butyric acid on colorectal carcinoma bearing mice
por: Kapuvári, Bence, et al.
Publicado: (2016)

Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer
por: Fiascarelli, Alessio, et al.
Publicado: (2023)

Concordance of the 21-gene assay between core needle biopsy and resection specimens in early breast cancer patients
por: Qi, Peng, et al.
Publicado: (2021)

Novaferon, a novel recombinant protein produced by DNA-shuffling of IFN-α, shows antitumor effect in vitro and in vivo
por: Li, Meng, et al.
Publicado: (2014)

Comparison of protein expression between formalin-fixed core-cut biopsies and surgical excision specimens using a novel multiplex approach
por: Leal, Mariana Ferreira, et al.
Publicado: (2019)

Patterns of biomarker expression in patients treated with primary endocrine therapy – a unique insight using core needle biopsy tissue microarray
por: Parks, R. M., et al.
Publicado: (2020)

Anti-EGFR-iRGD recombinant protein conjugated silk fibroin nanoparticles for enhanced tumor targeting and antitumor efficiency
por: Bian, Xinyu, et al.
Publicado: (2016)

CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo
por: Koch, Manuel, et al.
Publicado: (2010)

Fatty Acids Prevent Hypoxia-Inducible Factor-1α Signaling Through Decreased Succinate in Diabetes
por: Dodd, Michael S., et al.
Publicado: (2018)

Histone methyltransferases regulate the transcriptional expression of ERα and the proliferation of tamoxifen-resistant breast cancer cells
por: Kim, Seung-Su, et al.
Publicado: (2020)

IFN-γ-STAT1-ERK Pathway Mediates Protective Effects of Invariant Natural Killer T Cells Against Doxorubicin-Induced Cardiomyocyte Death
por: Sada, Masashi, et al.
Publicado: (2023)

Estrogen Receptor-α Non-Nuclear Signaling Confers Cardioprotection and Is Essential to cGMP-PDE5 Inhibition Efficacy
por: Fukuma, Nobuaki, et al.
Publicado: (2020)

Investigating the role of endogenous estrogens, hormone replacement therapy, and blockade of estrogen receptor-α activity on breast metabolic signaling
por: Arnone, Alana A., et al.
Publicado: (2021)

Emodin induced necroptosis in the glioma cell line U251 via the TNF-α/RIP1/RIP3 pathway
por: Zhou, Jiabin, et al.
Publicado: (2019)

Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes
por: Teinturier, Romain, et al.
Publicado: (2021)

DC-SCRIPT is a novel regulator of the tumor suppressor gene CDKN2B and induces cell cycle arrest in ERα-positive breast cancer cells
por: Ansems, Marleen, et al.
Publicado: (2015)

Cyclic RGD-Decorated Liposomal Gossypol AT-101 Targeting for Enhanced Antitumor Effect
por: Liu, Hao, et al.
Publicado: (2022)

Akt and its phosphorylation in nucleus accumbens mediate heroin‐seeking behavior induced by cues in rats
por: Zhu, Huaqiang, et al.
Publicado: (2021)

Evaluation of anti-EGFR-iRGD recombinant protein with GOLD nanoparticles: synergistic effect on antitumor efficiency using optimized deep neural networks
por: Chandra Kaushik, Aman, et al.
Publicado: (2019)

Ultrasound and clinicopathological characteristics-based model for prediction of pathologic response to neoadjuvant chemotherapy in HER2-positive breast cancer: a case–control study
por: Sui, Lin, et al.
Publicado: (2023)

Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment
por: Zhang, Zhen, et al.
Publicado: (2018)

Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy
por: Li, Kai, et al.
Publicado: (2020)

Osthole inhibits the progression of human gallbladder cancer cells through JAK/STAT3 signal pathway both in vitro and in vivo
por: Le Zou, Tian, et al.
Publicado: (2019)

Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma
por: Butterfield, Lisa H., et al.
Publicado: (2019)

Talin2 regulates invasion of human breast cancer MDA-MB-231 cells via alteration of the tumor microenvironment
por: Wen, Zhengwei, et al.
Publicado: (2019)

Targeted Recombinant Fusion Proteins of IFNγ and Mimetic IFNγ with PDGFβR Bicyclic Peptide Inhibits Liver Fibrogenesis In Vivo
por: Bansal, Ruchi, et al.
Publicado: (2014)

The Differential Antiviral Activities of Chicken Interferon α (ChIFN-α) and ChIFN-β are Related to Distinct Interferon-Stimulated Gene Expression
por: Qu, Hongren, et al.
Publicado: (2013)

Recombinant IFN-α2a-NGR exhibits higher inhibitory function on tumor neovessels formation compared with IFN-α2a in vivo and in vitro
por: Li, Weina, et al.
Publicado: (2014)

Use of Recombinant Adenovirus Vectored Consensus IFN-α to Avert Severe Arenavirus Infection
por: Gowen, Brian B., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_mmlfkjfn86aop0l1a26mp718ph